Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
Invesco S&P 500 High Beta ETF
SPHB
$947M
| $102K | ﹤0.01% |
1,300
| – | – |
|
4277
Taylor Devices
TAYD
$172M
| $102K | ﹤0.01% |
3,151
-1,437
| -31% | -$47.2K |
|
|
SBT
4278
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $102K | ﹤0.01% |
20,986
-11,023
| -34% | -$52.1K |
|
|
OBE
4279
Obsidian Energy
OBE
$695M
| $102K | ﹤0.01% |
17,326
+286
| +2% | +$1.58K |
|
4280
FT Vest US Equity Deep Buffer ETF July
DJUL
$457M
| $101K | ﹤0.01% |
2,477
+1,789
| +260% | +$75.4K |
|
4281
Urban One Class A
UONE
$23.3M
| $101K | ﹤0.01% |
7,028
| – | – |
|
4282
Mammoth Energy Services
TUSK
$158M
| $101K | ﹤0.01% |
49,521
-12,028
| -20% | -$32.1K |
|
|
GOCO
4283
DELISTED
GoHealth
GOCO
| $101K | ﹤0.01% |
8,219
-2,285
| -22% | -$34.9K |
|
|
AFCG
4284
AFC Gamma
AFCG
$64.3M
| $101K | ﹤0.01% |
18,052
-7,398
| -29% | -$58.8K |
|
|
STRS
4285
DELISTED
STRATUS PPTYS INC
STRS
| $99.9K | ﹤0.01% |
5,627
-2,789
| -33% | -$52.9K |
|
4286
AdvisorShares Pure US Cannabis ETF
MSOS
$916M
| $99.8K | ﹤0.01% |
38,221
| – | – |
|
4287
Suzano
SUZ
$9.88B
| $98.9K | ﹤0.01% |
10,650
| – | – |
|
4288
Ambev
ABEV
$43.5B
| $98.9K | ﹤0.01% |
42,458
+41,193
| +3,256% | +$82.4K |
|
4289
Taboola.com
TBLA
$1.05B
| $98.8K | ﹤0.01% |
33,502
-344
| -1% | -$1.18K |
|
4290
Lyell Immunopharma
LYEL
$347M
| $98.7K | ﹤0.01% |
9,173
-3,746
| -29% | -$45.9K |
|
4291
RUM Group Inc
RUM
$2.08B
| $98.5K | ﹤0.01% |
13,926
+1,458
| +12% | +$15.2K |
|
4292
Wheels Up
UP
$190M
| $98.4K | ﹤0.01% |
4,870
-2,233
| -31% | -$61.5K |
|
4293
HUTCHMED
HCM
$2.13B
| $97.9K | ﹤0.01% |
6,509
+4,102
| +170% | +$60.7K |
|
|
IIF
4294
Morgan Stanley India Investment Fund
IIF
$220M
| $97.6K | ﹤0.01% |
4,000
| – | – |
|
4295
DHI Group
DHX
$166M
| $97.5K | ﹤0.01% |
70,154
-4,955
| -7% | -$11.2K |
|
4296
Cardlytics
CDLX
$24.7M
| $97.3K | ﹤0.01% |
5,343
-1,983
| -27% | -$56.6K |
|
4297
Pliant Therapeutics
PLRX
$66.3M
| $97.1K | ﹤0.01% |
71,912
-29,911
| -29% | -$182K |
|
4298
Amprius Technologies
AMPX
$1.79B
| $96.9K | ﹤0.01% |
36,175
-8,285
| -19% | -$24.4K |
|
4299
Achieve Life Sciences
ACHV
$687M
| $96.9K | ﹤0.01% |
36,301
-17,172
| -32% | -$53.4K |
|
4300
AllianzIM U.S. Equity Buffer10 Jul ETF
JULT
$57.4M
| $96.8K | ﹤0.01% |
+2,531
| New | +$100K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.